- Home
- WWW vs QURE Comparison
WWW vs QURE Comparison
Compare WWW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWW | QURE |
|---|---|---|
| Founded | 1883 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | WWW | QURE |
|---|---|---|
| Price | $19.19 | $22.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $23.86 | ★ $58.55 |
| AVG Volume (30 Days) | 1.8M | ★ 2.0M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $1,851,500,000.00 | $15,751,000.00 |
| Revenue This Year | $7.35 | N/A |
| Revenue Next Year | $5.20 | $142.93 |
| P/E Ratio | $18.06 | ★ N/A |
| Revenue Growth | ★ 3.61 | N/A |
| 52 Week Low | $9.58 | $7.76 |
| 52 Week High | $32.80 | $71.50 |
Technical Indicators
Market Signals| Indicator | WWW | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 44.78 |
| Support Level | $17.96 | $21.15 |
| Resistance Level | $19.48 | $28.77 |
| Average True Range (ATR) | 0.82 | 1.60 |
| MACD | 0.11 | 0.23 |
| Stochastic Oscillator | 83.05 | 21.85 |
Price Performance
Historical ComparisonAbout WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.